𝔖 Bobbio Scriptorium

✦ LIBER ✦

Response to comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulphonylureas and metformin. Diabetologia 49:930–936

✍ Scribed by J. M. M. Evans; A. D. Morris

Publisher: Springer
Year: 2007
Tongue: English
Weight: 47 KB
Volume: 50
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-007-0632-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comment on: Evans JMM, Ogston SA, Emslie

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

✍ J. A. Tayek 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 62 KB

Comment on: Evans JMM, Ogston SA, Emslie

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

✍ D. Raccah 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 62 KB

Comment on: Evans JM, Ogston SA, Emslie-

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

✍ J. A. Johnson; S. H. Simpson; D. T. Eurich; S. R. Majumdar 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 60 KB

Risk of mortality and adverse cardiovasc

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

✍ J. M. M. Evans; S. A. Ogston; A. Emslie-Smith; A. D. Morris 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 176 KB